by ZPHC
Arimidex 1mg tablets by ZPHC. Non-steroidal aromatase inhibitor.
In stock
Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.
Batch certificate of analysis available on request via Telegram or the contact form.
ZPHC Anastrozole 1mg is a potent non-steroidal aromatase inhibitor that reversibly blocks the cytochrome P450 enzyme aromatase, reducing peripheral estrogen synthesis by approximately 97% at therapeutic doses. Originally developed for breast cancer treatment, anastrozole is studied in androgen research for on-cycle estrogen management, gynecomastia prevention and post-cycle HPG axis recovery support. Its reversible, non-steroidal mechanism allows complete enzyme activity restoration after washout — unlike steroidal AIs.
24–50 hour half-life, once-daily dosing. 100-tablet pack, ZPHC GMP-grade production, Janoshik-verified 99%+ purity. For laboratory research use only.
PCT & Support
Testosterone maintains bone density through both direct AR-mediated osteoblast activation and indirect estradiol-mediated osteoclast suppression. Advanced research guide covering androgen effects on bone remodeling, the aromatization requirement, and compound research for osteoporosis models.
5 min read
PCT & Support
Aromatase is the enzyme responsible for estrogen biosynthesis from androgen precursors. Research guide covering CYP19A1 mechanism, tissue expression, role in androgen metabolism, aromatase inhibitor pharmacology, and why aromatization is a key variable in anabolic research models.
5 min read
PCT & Support
Anastrozole and exemestane both inhibit the CYP19A1 aromatase enzyme but through fundamentally different mechanisms — reversible binding vs. irreversible mechanism-based inactivation. Research comparison of pharmacology, enzyme kinetics, selectivity profiles, and bone effects for AI research compound selection.
4 min read
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.
Hilma Biocare
Potent aromatase inhibitor. Studied for estrogen control during hormonal research.
99.3%· Janoshik
Hilma Biocare
Strong aromatase inhibitor. More potent estrogen suppression than Anastrozole.
99.2%· Janoshik
Hilma Biocare
Steroidal aromatase inactivator. Suicide AI for complete estrogen blockade.
99.0%· Janoshik
Hilma Biocare
SERM for HPTA recovery. Studies LH/FSH stimulation post-cycle.
99.4%· Janoshik
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer